Top

Journal of Diabetes & Metabolic Disorders

Published in:

01-06-2021 | Research article

Gene set enrichment analysis of PPAR-γ regulators from Murraya odorata Blanco

Authors: Prarambh SR Dwivedi, V. P. Rasal, Ekta Kotharkar, Shailaja Nare, Pukar Khanal

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2021

Abstract

Background

Peroxisome proliferator-activated receptor gamma (PPAR-γ) is reported to regulate insulin sensitivity and progression of Type 2 diabetes mellitus (T2DM). Hence the present study is aimed to identify PPAR-γ regulators from Murraya odorata Blanco and predict their role to manage T2DM.

Methods

Multiple in-silico tools and databases like SwissTargetPrediction, ADVERPred, PubChem, and MolSoft, were used to retrieve the information related to bioactives, targets, druglikeness character, and probable side effects as applicable. Similarly, the Kyoto Encyclopedia of Genes and Genomes (KEGG) database was used to identify the regulated pathways. Further, the bioactives-protein-pathways network interaction was constructed using Cytoscape. Finally, molecular docking was performed using Autodock4.

Results

Twenty-five bioactives were shortlisted in which six were predicted as PPAR-γ modulators. Among them, stigmasterol was predicted to possess the best binding affinity towards PPAR-γ and possessed no side effects. Similarly, n-hexadecanoic acid was predicted to modulate the highest number of proteins, and protein CD14 was targeted by the highest number of bioactives. Further, the PI3K-Akt pathway was predicted as the maximum modulated genes.

Conclusions

The anti-diabetic property of the Murraya odorata Blanco of fruit pulp may be due to the presence of n-hexadecanoic acid and stigmasterol; may also involve in the regulation of the PI3K-Akt pathway which needs further investigated by in-vitro and in-vivo protocols.

Baynes HW. Classification, pathophysiology, diagnosis and management of diabetes mellitus. J Diabetes Metab. 2015;6(5):1–9. https://doi.org/10.4172/2155-6156.1000541.CrossRef

Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem. 1995;270(22):12953–6. https://doi.org/10.1074/jbc.270.22.12953.CrossRefPubMed

Spiegelman BM. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. J Diabetes. 1998;47(4):507–14. https://doi.org/10.2337/diabetes.47.4.507.CrossRef

Larsen TM, Toubro S, Astrup A. PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int J Obes (Lond). 2003;27(2):147–61. https://doi.org/10.1038/sj.ijo.802223.CrossRef

Krentz AJ, Bailey CJ. Oral antidiabetic agents. Drugs. 2005;65(3):385–411. https://doi.org/10.2165/00003495-200565030-00005.CrossRefPubMed

Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care. 1989;12(8):553–64. https://doi.org/10.2337/diacare.12.8.553.CrossRefPubMed

Khanal P, Patil BM. Gene ontology enrichment analysis of α-amylase inhibitors from Duranta repens in diabetes mellitus. J Diabetes Metab Disord. 2020. https://doi.org/10.1007/s40200-020-00554-9.CrossRefPubMedPubMedCentral

Jayakumar R. Herbal medicines for type-2 diabetes. Int J Diabetes Dev Ctries. 2010;30(3):111. https://doi.org/10.4103/0973-3930.66501.CrossRef

Terstappen GC, Reggiani A. In silico research in drug discovery. Trends Pharmacol Sci. 2001;22(1):23–6. https://doi.org/10.1016/S0165-6147(00)01584-4.CrossRefPubMed

10.

Khanal P, Chikhale R, Dey YN, Pasha I, Chand S, Gurav N, Ayyanar M, Patil BM, Gurav S. Withanolides from Withania somnifera as an immunity booster and their therapeutic options against COVID-19. J Biomol Struct Dyn. 2021. https://doi.org/10.1080/07391102.2020.1869588.

11.

Muthulakshmi AR, Margret RJ, Mohan VR. GC-MS analysis of bioactive components of Feronia elephantum Correa (Rutaceae). J Appl Pharm Sci. 2012;2(02):69–74.

12.

Maity P, Hansda D, Bandyopadhyay U, Mishra DK. Biological activities of crude extracts and chemical constituents of Bael, Aegle marmelos (L.) Corr. Indian J Exp Biol. 2009;47:849–61.

13.

Sabu MC, Kuttan R. Antidiabetic activity of Aegle marmelos and its relationship with its antioxidant properties. Indian J Physiol Pharmacol. 2004;48(1):81–8.PubMed

14.

Mishra A, Garg GP. Antidiabetic activity of fruit pulp of Feronia elephantum Corr. Pharmacogn J. 2011;3(20):27–32. https://doi.org/10.5530/pj.2011.20.6.CrossRef

15.

Intekhab J, Aslam M. Constituents from Feronia limonia. An Univ Bucuresti Chimie. 2009;18(2):95–101.

16.

Pandey S, Satpathy G, Gupta RK. Evaluation of nutritional, phytochemical, antioxidant and antibacterial activity of exotic fruit “Limonia acidissima”. J Pharmacogn Phytochem. 2014;3(2):81–8.

17.

Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Han L, He J, He S, Shoemaker BA, Wang J. PubChem substance and compound databases. Nucleic Acids Res. 2016;44(D1):D1202-13. https://doi.org/10.1093/nar/gkv951.CrossRefPubMed

18.

Drug-Likeness and molecular property prediction. molsoft molecules in silico. Available at: https://molsoft.com/mprop/. Accessed 18 Nov 2020.

19.

Ivanov SM, Lagunin AA, Rudik AV, Filimonov DA, Poroikov VV. ADVERPred–Web service for prediction of adverse effects of drugs. J Chem Inf Model. 2018;58(1):8–11. https://doi.org/10.1021/acs.jcim.7b00568.CrossRefPubMed

20.

Lagunin A, Ivanov S, Rudik A, Filimonov D, Poroikov V. DIGEP-Pred: web service for in silico prediction of drug-induced gene expression profiles based on structural formula. Bioinformatics. 2013;29(16):2062–3. https://doi.org/10.1093/bioinformatics/btt322.CrossRefPubMed

21.

Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–13.CrossRef

22.

Khanal P, Dey YN, Patil R, Chikhale R, Wanjari MM, Gurav SS, Patil BM, Srivastava B, Gaidhani SN. Combination of system biology to probe the anti-viral activity of andrographolide and its derivative against COVID-19. RSC Adv. 2021;11(9):5065–79. https://doi.org/10.1039/D0RA10529E.CrossRef

23.

Bindea G, Galon J, Mlecnik B. CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data. Bioinformatics. 2013;29(5):661–3. https://doi.org/10.1093/bioinformatics/btt019.CrossRef

24.

Khanal P, Duyu T, Patil BM, Dey YN, Pasha I, Wanjari M, Gurav SS, Maity A. Network pharmacology of AYUSH recommended immune-boosting medicinal plants against COVID-19. J Ayurveda Integr Med. 2020. https://doi.org/10.1016/j.jaim.2020.11.004.

25.

Halgren TA. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem. 1996;17(5-6):490–519. https://doi.org/10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P.CrossRef

26.

Biovia DS. Discovery studio visualizer. San Diego, CA, USA. 2017. pp. 936. Available link:https://discover.3ds.com/discovery-studio-visualizer-download.

27.

Oo WM, Khine MM. Pharmacological properties of Feronia limonia fruit pulp–a review. Indo Am J Pharm Sci. 2017;7(04):8213–9.

28.

Moreno E, Cordobilla R, Calvet T, Lahoz FJ, Balana AI. The C form of n-hexadecanoic acid. Acta Crystallogr Sect C Cryst Struct Commun. 2006;62(3):o129-31. https://doi.org/10.1107/S0108270106003106.CrossRef

29.

Bibo AM, Peterson IR. Phase diagrams of monolayers of the long chain fatty acids. Adv Mater. 1990;2(6-7):309–11. https://doi.org/10.1002/adma.19900020608.CrossRef

30.

Khanal P, Patil BM. Integration of network and experimental pharmacology to decipher the antidiabetic action of Duranta repens L. J Integr Med. 2020. https://doi.org/10.1016/j.joim.2020.10.003.CrossRefPubMed

31.

Walters WP, Murcko MA. Prediction of ‘drug-likeness’. Adv Drug Deliv Rev. 2002;54(3):255–71. https://doi.org/10.1016/S0169-409X(02)00003-0.CrossRefPubMed

32.

Huang X, Liu G, Guo J, Su Z. The PI3K/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018;14(11):1483–96. https://doi.org/10.7150/ijbs.27173.CrossRefPubMed

33.

Xiao H, Gu Z, Wang G, Zhao T. The possible mechanisms underlying the impairment of HIF-1α pathway signaling in hyperglycemia and the beneficial effects of certain therapies. Int J Med Sci. 2013;10(10):1412–21. https://doi.org/10.7150/ijms.5630.CrossRefPubMedPubMedCentral

34.

Kay AM, Simpson CL, Stewart JA Jr. The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular Calcification. J Diabetes Res. 2016;2016:6809703. doi:https://doi.org/10.1155/2016/6809703.CrossRefPubMedPubMedCentral

Title: Gene set enrichment analysis of PPAR-γ regulators from Murraya odorata Blanco
Authors: Prarambh SR Dwivedi
V. P. Rasal
Ekta Kotharkar
Shailaja Nare
Pukar Khanal
Publication date: 01-06-2021
Publisher: Springer International Publishing
Published in: Journal of Diabetes & Metabolic Disorders / Issue 1/2021
Electronic ISSN: 2251-6581
DOI: https://doi.org/10.1007/s40200-021-00754-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Gene set enrichment analysis of PPAR-γ regulators from Murraya odorata Blanco

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Type 2 diabetes: patient assessment of chronic illness care

Distress and depression among patients with diabetes mellitus: prevalence and associated factors: a cross‐sectional study

More than a quarter of century of excellence in research, clinical care, and education

Significant association of LXRβ (NR1H2) polymorphisms (rs28514894, rs2303044) with type 2 diabetes mellitus and laboratory characteristics

Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis

The investigation of the efficacy ratio of cress seeds supplementation to moderate hyperglycemia and hepatotoxicity in streptozotocin‐induced diabetic rats

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page